INS and type 2 diabetes mellitus: Recently, the incretin effect has been observed to be reduced in patients with type 2 diabetes mellitus, which is a symptom of increased insulin secretion induced by oral administration, such as eating a meal, compared to intravenous administration of glucose [56].